Acceder

Publicaciones - Terapias moleculares y biomarcadores de tumores sólidos

Cargando...
Sánchez J, García A, Ruiz JM, Montes AM, Cabezas-Herrera J, Ros-Lara S, De la Cruz E, Gutiérrez AM. Porcine Breed, Sex, and Production Stage Influence the Levels of Health Status Biomarkers in Saliva Samples. Front Vet Sci. 2019 Feb 14;6:32. doi: 10.3389/fvets.2019.00032. eCollection 2019. PubMed PMID: 30838222; PubMed Central PMCID: PMC6382678.
AÑO: 2019; IF: 2.245
Garcia-Jimenez A, Teruel-Puche JA, Garcia-Ruiz PA, Saura-Sanmartin A, Berna J, Rodríguez-López JN, Garcia-Canovas F. Action of tyrosinase on caffeic acid and its n-nonyl ester. Catalysis and suicide inactivation. Int J Biol Macromol. 2018 Feb;107(Pt B):2650-2659. doi: 10.1016/j.ijbiomac.2017.10.151. Epub 2017 Oct 31. PubMed PMID: 29080822.
AÑO: 2018; IF: 4.784
Garcia-Jimenez A, García-Molina F, Teruel-Puche JA, Saura-Sanmartin A, Garcia-Ruiz PA, Ortiz-Lopez A, Rodríguez-López JN, Garcia-Canovas F, Munoz-Munoz J. Catalysis and inhibition of tyrosinase in the presence of cinnamic acid and some of its derivatives. Int J Biol Macromol. 2018 Nov;119:548-554. doi: 10.1016/j.ijbiomac.2018.07.173. Epub 2018 Jul 29. PubMed PMID: 30063931.
AÑO: 2018; IF: 4.784
Castillo-Guardiola V, Sarabia-Meseguer MD, Marín-Vera M, Sánchez-Bermúdez AI, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer. Cancer Genet. 2018 Dec;228-229:1-4. doi: 10.1016/j.cancergen.2018.06.002. Epub 2018 Jun 23. PubMed PMID: 30553462.
AÑO: 2018; IF: 2.183
Marín Hernández C, Piñero Madrona A, Gil Vázquez PJ, Galindo Fernández PJ, Ruiz Merino G, Alonso Romero JL, Parrilla Paricio P. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Clin Transl Oncol. 2018 Apr;20(4):476-483. doi: 10.1007/s12094-017-1732-0. Epub 2017 Aug 7. PubMed PMID: 28785911.
AÑO: 2018; IF: 2.441
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Terapias moleculares y biomarcadores de tumores sólidos